Literature DB >> 17301157

Switching the substrate specificity of the two-component NS2B-NS3 flavivirus proteinase by structure-based mutagenesis.

Sergey A Shiryaev1, Boris I Ratnikov, Alexander E Aleshin, Igor A Kozlov, Nicholas A Nelson, Michal Lebl, Jeffrey W Smith, Robert C Liddington, Alex Y Strongin.   

Abstract

The flavivirus NS2B-NS3(pro)teinase is an essential element in the proteolytic processing of the viral precursor polyprotein and therefore a potential drug target. Recently, crystal structures and substrate preferences of NS2B-NS3pro from Dengue and West Nile viruses (DV and WNV) were determined. We established that the presence of Gly-Gly at the P1'-P2' positions is optimal for cleavage by WNV NS3pro, whereas DV NS3pro tolerates well the presence of bulky residues at either P1' or P2'. Structure-based modeling suggests that Arg(76) and Pro(131)-Thr(132) limit the P1'-P2' subsites and restrict the cleavage preferences of the WNV enzyme. In turn, Leu(76) and Lys(131)-Pro(132) widen the specificity of DV NS3pro. Guided by these structural models, we expressed and purified mutant WNV NS2B-NS3pro and evaluated cleavage preferences by using positional scanning of the substrate peptides in which the P4-P1 and the P3'-P4' positions were fixed and the P1' and P2' positions were each randomized. We established that WNV R76L and P131K-T132P mutants acquired DV-like cleavage preferences, whereas T52V had no significant effect. Our work is the first instance of engineering a viral proteinase with switched cleavage preferences and should provide valuable data for the design of optimized substrates and substrate-based selective inhibitors of flaviviral proteinases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301157      PMCID: PMC1900165          DOI: 10.1128/JVI.02719-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Unexpected similarity between the cytosolic West Nile virus NS3 and the secretory furin-like serine proteinases.

Authors:  Nabil G Seidah
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

2.  Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries.

Authors:  Jun Li; Siew Pheng Lim; David Beer; Viral Patel; Daying Wen; Christine Tumanut; David C Tully; Jennifer A Williams; Jan Jiricek; John P Priestle; Jennifer L Harris; Subhash G Vasudevan
Journal:  J Biol Chem       Date:  2005-06-01       Impact factor: 5.157

3.  A method for rapid protease substrate evaluation and optimization.

Authors:  Igor A Kozlov; Peter C Melnyk; Chanfeng Zhao; John P Hachmann; Veronika Shevchenko; Anu Srinivasan; David L Barker; Michal Lebl
Journal:  Comb Chem High Throughput Screen       Date:  2006-07       Impact factor: 1.339

4.  Upregulation of signalase processing and induction of prM-E secretion by the flavivirus NS2B-NS3 protease: roles of protease components.

Authors:  V F Yamshchikov; D W Trent; R W Compans
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

5.  Yellow fever virus NS2B-NS3 protease: characterization of charged-to-alanine mutant and revertant viruses and analysis of polyprotein-cleavage activities.

Authors:  Thomas J Chambers; Deborah A Droll; Yujia Tang; Yan Liang; Vannakambadi K Ganesh; Krishna H M Murthy; Michael Nickells
Journal:  J Gen Virol       Date:  2005-05       Impact factor: 3.891

Review 6.  West Nile virus in the vertebrate world.

Authors:  K M van der Meulen; M B Pensaert; H J Nauwynck
Journal:  Arch Virol       Date:  2005-01-19       Impact factor: 2.574

7.  Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation.

Authors:  Pornwaratt Niyomrattanakit; Pakorn Winoyanuwattikun; Santad Chanprapaph; Chanan Angsuthanasombat; Sakol Panyim; Gerd Katzenmeier
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

8.  Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design.

Authors:  H M Murthy; K Judge; L DeLucas; R Padmanabhan
Journal:  J Mol Biol       Date:  2000-08-25       Impact factor: 5.469

9.  Modulation of the nucleoside triphosphatase/RNA helicase and 5'-RNA triphosphatase activities of Dengue virus type 2 nonstructural protein 3 (NS3) by interaction with NS5, the RNA-dependent RNA polymerase.

Authors:  Changsuek Yon; Tadahisa Teramoto; Niklaus Mueller; Jessica Phelan; Vannakambadi K Ganesh; Krishna H M Murthy; R Padmanabhan
Journal:  J Biol Chem       Date:  2005-05-24       Impact factor: 5.157

10.  Enzymatic characterization and homology model of a catalytically active recombinant West Nile virus NS3 protease.

Authors:  Tessa A Nall; Keith J Chappell; Martin J Stoermer; Ning-Xia Fang; Joel D A Tyndall; Paul R Young; David P Fairlie
Journal:  J Biol Chem       Date:  2004-08-18       Impact factor: 5.157

View more
  25 in total

1.  Structural and functional parameters of the flaviviral protease: a promising antiviral drug target.

Authors:  Sergey A Shiryaev; Alex Y Strongin
Journal:  Future Virol       Date:  2010-09-01       Impact factor: 1.831

Review 2.  Molecular targets for flavivirus drug discovery.

Authors:  Aruna Sampath; R Padmanabhan
Journal:  Antiviral Res       Date:  2008-09-15       Impact factor: 5.970

3.  Substrate cleavage analysis of furin and related proprotein convertases. A comparative study.

Authors:  Albert G Remacle; Sergey A Shiryaev; Eok-Soo Oh; Piotr Cieplak; Anupama Srinivasan; Ge Wei; Robert C Liddington; Boris I Ratnikov; Amelie Parent; Roxane Desjardins; Robert Day; Jeffrey W Smith; Michal Lebl; Alex Y Strongin
Journal:  J Biol Chem       Date:  2008-05-27       Impact factor: 5.157

4.  Context-Dependent Cleavage of the Capsid Protein by the West Nile Virus Protease Modulates the Efficiency of Virus Assembly.

Authors:  Laura A VanBlargan; Kaitlin A Davis; Kimberly A Dowd; David L Akey; Janet L Smith; Theodore C Pierson
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

5.  Virtual ligand screening of the National Cancer Institute (NCI) compound library leads to the allosteric inhibitory scaffolds of the West Nile Virus NS3 proteinase.

Authors:  Sergey A Shiryaev; Anton V Cheltsov; Katarzyna Gawlik; Boris I Ratnikov; Alex Y Strongin
Journal:  Assay Drug Dev Technol       Date:  2010-11-04       Impact factor: 1.738

6.  Structure-guided fragment-based in silico drug design of dengue protease inhibitors.

Authors:  Tim Knehans; Andreas Schüller; Danny N Doan; Kassoum Nacro; Jeffrey Hill; Peter Güntert; M S Madhusudhan; Tanja Weil; Subhash G Vasudevan
Journal:  J Comput Aided Mol Des       Date:  2011-02-23       Impact factor: 3.686

7.  Ligand-bound structures of the dengue virus protease reveal the active conformation.

Authors:  Christian G Noble; Cheah Chen Seh; Alexander T Chao; Pei Yong Shi
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

8.  Substrate inhibition kinetic model for West Nile virus NS2B-NS3 protease.

Authors:  Suzanne M Tomlinson; Stanley J Watowich
Journal:  Biochemistry       Date:  2008-10-15       Impact factor: 3.162

9.  A femtomol range FRET biosensor reports exceedingly low levels of cell surface furin: implications for the processing of anthrax protective antigen.

Authors:  Katarzyna Gawlik; Albert G Remacle; Sergey A Shiryaev; Vladislav S Golubkov; Mingxing Ouyang; Yingxiao Wang; Alex Y Strongin
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

10.  The two-component NS2B-NS3 proteinase represses DNA unwinding activity of the West Nile virus NS3 helicase.

Authors:  Andrei V Chernov; Sergey A Shiryaev; Alexander E Aleshin; Boris I Ratnikov; Jeffrey W Smith; Robert C Liddington; Alex Y Strongin
Journal:  J Biol Chem       Date:  2008-04-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.